276 related articles for article (PubMed ID: 33417686)
1. No Venous Thromboembolism Increase Among Transgender Female Patients Remaining on Estrogen for Gender-Affirming Surgery.
Kozato A; Fox GWC; Yong PC; Shin SJ; Avanessian BK; Ting J; Ling Y; Karim S; Safer JD; Pang JH
J Clin Endocrinol Metab; 2021 Mar; 106(4):e1586-e1590. PubMed ID: 33417686
[TBL] [Abstract][Full Text] [Related]
2. Estrogen Continuation and Venous Thromboembolism in Penile Inversion Vaginoplasty.
Nolan IT; Haley C; Morrison SD; Pannucci CJ; Satterwhite T
J Sex Med; 2021 Jan; 18(1):193-200. PubMed ID: 33243691
[TBL] [Abstract][Full Text] [Related]
3. Incidence and Risk Factors for Postoperative Venous Thromboembolism After Gender Affirming Vaginoplasty: A Retrospective Analysis of a Large Insurance Claims Database.
Snyder L; Hebert KJ; Horns JJ; Schardein J; McCormick BJ; Downing J; Dy GW; Goodwin I; Agarwal C; Hotaling JM; Myers JB
Urology; 2023 Dec; 182():95-100. PubMed ID: 37774849
[TBL] [Abstract][Full Text] [Related]
4. Effect of Cross-Sex Hormone Therapy on Venous Thromboembolism Risk in Male-to-Female Gender-Affirming Surgery.
Haveles CS; Wang MM; Arjun A; Zaila KE; Lee JC
Ann Plast Surg; 2021 Jan; 86(1):109-114. PubMed ID: 32079810
[TBL] [Abstract][Full Text] [Related]
5. Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.
Totaro M; Palazzi S; Castellini C; Parisi A; D'Amato F; Tienforti D; Baroni MG; Francavilla S; Barbonetti A
Front Endocrinol (Lausanne); 2021; 12():741866. PubMed ID: 34880832
[TBL] [Abstract][Full Text] [Related]
6. Assessing and Addressing the Risk of Venous Thromboembolism Across the Spectrum of Gender Affirming Care: A Review.
Arrington-Sanders R; Connell NT; Coon D; Dowshen N; Goldman AL; Goldstein Z; Grimstad F; Javier NM; Kim E; Murphy M; Poteat T; Radix A; Schwartz A; St Amand C; Streed CG; Tangpricha V; Toribio M; Goldstein RH
Endocr Pract; 2023 Apr; 29(4):272-278. PubMed ID: 36539066
[TBL] [Abstract][Full Text] [Related]
7. Continuing perioperative estrogen therapy does not increase venous thromboembolic events in transgender patients: a systematic review and meta-analysis.
Badreddine J; Lee MH; Mishra K; Pope R; Kim JY; Hong SH; Gupta S; Song JM; Shin JI; Ghayda RA
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2511-2517. PubMed ID: 35442466
[TBL] [Abstract][Full Text] [Related]
8. Venous Thromboembolism and Estrogen-Containing Gender-Affirming Hormone Therapy.
Dix C; Moloney M; Tran HA; McFadyen JD
Thromb Haemost; 2024 May; 124(5):387-398. PubMed ID: 37816389
[TBL] [Abstract][Full Text] [Related]
9. Risk for Venous Thromboembolism in Transgender Patients Undergoing Cross-Sex Hormone Treatment: A Systematic Review.
Kotamarti VS; Greige N; Heiman AJ; Patel A; Ricci JA
J Sex Med; 2021 Jul; 18(7):1280-1291. PubMed ID: 34140253
[TBL] [Abstract][Full Text] [Related]
10. Letter to the Editor from Blasdel et al: "No Venous Thromboembolism Increase Among Transgender Female Patients Remaining on Estrogen for Gender-affirming Surgery".
Blasdel G; Shakir N; Parker A; Bluebond-Langner R; Zhao L
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3783-e3784. PubMed ID: 33846750
[No Abstract] [Full Text] [Related]
11. Response to Letter to the Editor from Blasdel et al: "No Venous Thromboembolism Increase Among Transgender Female Patients Remaining on Estrogen for Gender Affirming Surgery".
Kozato A; Safer JD; Pang JH
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3791. PubMed ID: 33846741
[No Abstract] [Full Text] [Related]
12. Database Tracking in Gender-Affirming Surgery: Are Patients Falling Through the Cracks?
Doan TC; Wood Matabele KL; Nicksic PJ; Gast KM; Poore SO
WMJ; 2023 Jul; 122(3):184-186. PubMed ID: 37494648
[TBL] [Abstract][Full Text] [Related]
13. Minimizing Venous Thromboembolism in Feminizing Hormone Therapy: Applying Lessons From Cisgender Women and Previous Data.
Zucker R; Reisman T; Safer JD
Endocr Pract; 2021 Jun; 27(6):621-625. PubMed ID: 33819637
[TBL] [Abstract][Full Text] [Related]
14. HIGH BODY MASS INDEX IS A SIGNIFICANT BARRIER TO GENDER-CONFIRMATION SURGERY FOR TRANSGENDER AND GENDER-NONBINARY INDIVIDUALS.
Martinson TG; Ramachandran S; Lindner R; Reisman T; Safer JD
Endocr Pract; 2020 Jan; 26(1):6-15. PubMed ID: 31461357
[No Abstract] [Full Text] [Related]
15. Does Depth Matter? Factors Affecting Choice of Vulvoplasty Over Vaginoplasty as Gender-Affirming Genital Surgery for Transgender Women.
Jiang D; Witten J; Berli J; Dugi D
J Sex Med; 2018 Jun; 15(6):902-906. PubMed ID: 29706578
[TBL] [Abstract][Full Text] [Related]
16. Adverse events associated with gender affirming vaginoplasty surgery.
Ferrando CA
Am J Obstet Gynecol; 2020 Aug; 223(2):267.e1-267.e6. PubMed ID: 32446999
[TBL] [Abstract][Full Text] [Related]
17. No Thromboembolic Complications After Facial Feminization Surgery in Transgender Patients Utilizing Estrogen Therapy: A Retrospective Cohort Study.
Price R; Debryn D; Mukerji S; Nozari A; Spiegel JH; Kim E
Transgend Health; 2023 Aug; 8(4):344-351. PubMed ID: 37525836
[TBL] [Abstract][Full Text] [Related]
18. Perioperative Transgender Hormone Management: Avoiding Venous Thromboembolism and Other Complications.
Hontscharuk R; Alba B; Manno C; Pine E; Deutsch MB; Coon D; Schechter L
Plast Reconstr Surg; 2021 Apr; 147(4):1008-1017. PubMed ID: 33776045
[TBL] [Abstract][Full Text] [Related]
19. Perioperative Hormone Management in Gender-Affirming Mastectomy: Is Stopping Testosterone before Top Surgery Really Necessary?
Robinson IS; Rifkin WJ; Kloer C; Parker A; Blasdel G; Shakir N; Zhao LC; Bluebond-Langner R
Plast Reconstr Surg; 2023 Feb; 151(2):421-427. PubMed ID: 36374270
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
